Aspire Biopharma Holdings (ASBP) Current Assets (2021 - 2026)

Aspire Biopharma Holdings (ASBP) has 6 years of Current Assets data on file, last reported at $7.1 million in Q1 2026.

• On a quarterly basis, Current Assets rose 262.1% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 262.1% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 786.66% from the prior year.
• Current Assets for Q1 2026 stood at $7.1 million, up from $1.3 million in the prior quarter.
• Over the last five years, Current Assets for ASBP reached as high as $7.1 million in Q1 2026 and fell as low as $65577.0 in Q1 2024.
• Historically, Current Assets has averaged $1.3 million across 5 years, with a median of $1.0 million in 2022.
• Across the five-year window, Current Assets sank 92.77% in 2024 and surged 2897.26% in 2025, its largest moves.
• Year by year, Current Assets stood at $1.1 million in 2022, then tumbled by 92.6% to $81223.0 in 2023, then jumped by 82.2% to $147989.0 in 2024, then jumped by 786.66% to $1.3 million in 2025, then jumped by 442.4% to $7.1 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $7.1 million in Q1 2026, $1.3 million in Q4 2025, and $2.4 million in Q3 2025.